Transforming growth factor-β2 induces synthesis and secretion of endothelin-1 in human trabecular meshwork cells

Invest Ophthalmol Vis Sci. 2012 Aug 7;53(9):5279-86. doi: 10.1167/iovs.11-9289.

Abstract

Purpose: Analysis of aqueous humor from patients with primary open-angle glaucoma (POAG) revealed marked increases in the content of endothelin-1 (ET-1) and transforming growth factor-beta (TGF-β). We determined the consequences of TGF-β signaling on ET-1 expression and secretion by human trabecular meshwork (TM) cells.

Methods: Primary or transformed (NTM5 and GTM3) human TM cells conditioned in serum-free media were incubated in the absence or presence of TGF-β1 or -β2. Relative changes in preproendothelin (ppET)-1 mRNA content and secreted ET-1 peptide were quantified by real-time PCR and ELISA, respectively. In some experiments, TGF-β or ET-1 receptor antagonists, or Rho G-protein inhibitors, were evaluated for effects on TGF-β signaling. Filamentous actin organization was visualized by phalloidin.

Results: Primary or transformed human TM cells cultured in the presence of TGF-β1 or -β2 exhibit a marked (>8-fold) increase in ppET-1 mRNA content compared to vehicle controls. Coincubation with SB-505124, an inhibitor of TGFβRI/ALK-5 signaling, prevented TGF-β-mediated ppET-1 mRNA expression. In contrast, coincubation with ET(A) (BQ-123) or ET(B) (BQ-788) receptor antagonists had no effect on TGF-β-mediated ppET-1 mRNA expression. TGF-β1 and -β2 each elicited a robust (>7-fold) secretion of ET-1 while enhancing stress fiber organization. Inhibition of Rho signaling attenuated TGF-β-mediated increases in ppET-1 mRNA content, ET-1 secretion, and stress fiber organization.

Conclusions: TGF-β, signaling through the TGFβRI/ALK-5 receptor, elicits marked increases in ET-1 mRNA content and ET-1 secretion from cultured primary or transformed human TM cells. Elevated levels of TGF-β2 present in AH of POAG patients may elevate intraocular pressure, in part, by eliciting aberrant Rho G-protein dependent cell contraction, and increasing ET-1 synthesis and secretion, in human TM cells.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Actins / metabolism
  • Analysis of Variance
  • Benzodioxoles / pharmacology
  • Cadaver
  • Cell Line, Transformed
  • Endothelin-1 / biosynthesis*
  • Endothelin-1 / metabolism
  • Enzyme-Linked Immunosorbent Assay
  • Humans
  • Imidazoles / pharmacology
  • Lovastatin / pharmacology
  • Pyridines / pharmacology
  • RNA, Messenger / metabolism
  • Real-Time Polymerase Chain Reaction
  • Recombinant Proteins
  • Signal Transduction
  • Trabecular Meshwork / cytology
  • Trabecular Meshwork / metabolism*
  • Transforming Growth Factor beta2 / antagonists & inhibitors
  • Transforming Growth Factor beta2 / pharmacology
  • Transforming Growth Factor beta2 / physiology*

Substances

  • 2-(5-benzo(1,3)dioxol-5-yl-2-tert-butyl-3H-imidazol-4-yl)-6-methylpyridine hydrochloride
  • Actins
  • Benzodioxoles
  • Endothelin-1
  • Imidazoles
  • Pyridines
  • RNA, Messenger
  • Recombinant Proteins
  • Transforming Growth Factor beta2
  • Lovastatin